Home›Stock Screener›Omkar Pharmachem›Intrinsic Value

Omkar Pharmachem Intrinsic Value

Omkar Pharmachem intrinsic value. Omkar Pharmachem (OMKARPH) median intrinsic value is ₹19.70 from 1 valuation models (range ₹20–₹20), vs current price ₹7.88 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. For current market price and key ratios, visit Omkar Pharmachem stock price NSE.

Market Price (CMP)
₹7.88
Primary Intrinsic Value
₹19.70
Market Cap
₹7.9 Cr
+150.0% Upside
Median Value
₹19.70
Value Range
₹20 - ₹20
Assessment
Trading Below Calculated Value
Safety Margin
60.0%

OMKARPH Valuation Methods Summary — DCF, Graham Number & P/E

Omkar Pharmachem intrinsic value across 1 models vs current price ₹7.88 — upside/downside and value range per method. Analyse OMKARPH promoter holding to track promoter, FII and institutional holdings.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹19.70 ₹17.73 - ₹21.67 +150.0% Book Value/Share: ₹37.00, P/B: 1.0x
Method Types: Earnings Asset DCF Growth Dividend Conservative

OMKARPH Intrinsic Value vs Market Price — All Valuation Models

Omkar Pharmachem fair value range ₹20–₹20 vs current market price ₹7.88 across 1 valuation models. Browse OMKARPH cash flow statement for revenue, profit, balance sheet and cash flow data.

OMKARPH Intrinsic Value Analysis — Undervalued or Overvalued?

Omkar Pharmachem median intrinsic value ₹19.70, current price ₹7.88 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.

What is the intrinsic value of OMKARPH?

Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Omkar Pharmachem (OMKARPH) is ₹19.70 (median value). With the current market price of ₹7.88, this represents a +150.0% variance from our estimated fair value.

The valuation range spans from ₹19.70 to ₹19.70, indicating ₹19.70 - ₹19.70.

Is OMKARPH undervalued or overvalued?

Based on our multi-method analysis, Omkar Pharmachem (OMKARPH) appears to be trading below calculated value by approximately 150.0%.

OMKARPH Cash Flow Quality — Operating & Free Cash Flow

Omkar Pharmachem operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2025 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2024 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2023 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2022 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10